Induction chemotherapy in squamous cell carcinoma of the head and neck: Saved by the bell?

被引：1
作者：
Specenier, Pol [1 ]
机构：
[1] Univ Antwerp Hosp, Dept Oncol, B-2650 Edegem, Belgium
来源：
ORAL ONCOLOGY | 2015年 / 51卷 / 02期
关键词：
LOCALLY ADVANCED HEAD; PHASE-III; CANCER; CISPLATIN; FLUOROURACIL; RADIOTHERAPY; CHEMORADIOTHERAPY; METAANALYSIS; DOCETAXEL; CETUXIMAB;
D O I：
10.1016/j.oraloncology.2014.11.016
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E5 / E7
页数：3
相关论文
共 18 条
[1]  
[Anonymous], ASCO M
[2]   Cisplatin versus cetuximab plus concomitant radiotherapy in locally advanced head and neck cancer: A meta-analysis of published trials [J].
Barni, Sandro ;
Coinu, Andrea ;
Borgonovo, Karen ;
Cabiddu, Mary ;
Cremonesi, Marco ;
Petrelli, Fausto .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[3]  
Baujat B, 2010, COCHRANE DB SYST REV, V55
[4]   Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): A comprehensive analysis by tumour site [J].
Blanchard, Pierre ;
Baujat, Bertrand ;
Holostenco, Victoria ;
Bourredjem, Abderrahmane ;
Baey, Charlotte ;
Bourhis, Jean ;
Pignon, Jean-Pierre .
RADIOTHERAPY AND ONCOLOGY, 2011, 100 (01) :33-40
[5]   Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck [J].
Bonner, JA ;
Harari, PM ;
Giralt, J ;
Azarnia, N ;
Shin, DM ;
Cohen, RB ;
Jones, CU ;
Sur, R ;
Raben, D ;
Jassem, J ;
Ove, R ;
Kies, MS ;
Baselga, J ;
Youssoufian, H ;
Amellal, N ;
Rowinsky, EK ;
Ang, KK .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06) :567-578
[6]   Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival [J].
Bonner, James A. ;
Harari, Paul M. ;
Giralt, Jordi ;
Cohen, Roger B. ;
Jones, Christopher U. ;
Sur, Ranjan K. ;
Raben, David ;
Baselga, Jose ;
Spencer, Sharon A. ;
Zhu, Junming ;
Youssoufian, Hagop ;
Rowinsky, Eric K. ;
Ang, K. Kian .
LANCET ONCOLOGY, 2010, 11 (01) :21-28
[7]   Hyperfractionated or accelerated radiotherapy in head and neck cancer:: a meta-analysis [J].
Bourhis, Jean ;
Overgaard, Jens ;
Audry, Helene ;
Ang, Kian K. ;
Saunders, Michele ;
Bernier, Jacques ;
Horiot, Jean-Claude ;
Le Maitre, Aurlie ;
Pajak, Thomas F. ;
Paulsen, Michael G. ;
O'Sullivan, Brian ;
Dobrowsky, Werner ;
Hliniak, Andrzej ;
Skladowski, Krzysztof ;
Hay, John H. ;
Pinto, Luiz H. J. ;
Fallai, Carlo ;
Fu, Karen K. ;
Sylvester, Richard ;
Pignon, Jean-Pierre .
LANCET, 2006, 368 (9538) :843-854
[8]   Concomitant chemoradiation (CRT) or cetuximab/RT (CET/RT) versus induction Docetaxel/Cisplatin/5-Fluorouracil (TPF) followed by CRT or CET/RT in patients with Locally Advanced Squamous Cell Carcinoma of Head and Neck (LASCCHN). A randomized phase III factorial study (NCT01086826). [J].
Ghi, Maria Grazia ;
Paccagnella, Adriano ;
Ferrari, Daris ;
Foa, Paolo ;
Rocca, Maria Cossu ;
Verri, Elena ;
Morelli, Franco ;
Azzarello, Giuseppe ;
D'Ambrosio, Consuelo ;
Cruciani, Giorgio ;
Guaraldi, Monica ;
Massa, Elena ;
Rossetto, Ciro ;
Bonetti, Andrea ;
Siena, Salvatore ;
Minotti, Vincenzo ;
Koussis, Haralabos ;
Pieri, Gabriella ;
Baggio, Vittorio ;
Floriani, Irene .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[9]   Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J].
Gregoire, V. ;
Lefebvre, J. -L. ;
Licitra, L. ;
Felip, E. .
ANNALS OF ONCOLOGY, 2010, 21 :v184-v186
[10]   Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial [J].
Haddad, Robert ;
O'Neill, Anne ;
Rabinowits, Guilherme ;
Tishler, Roy ;
Khuri, Fadlo ;
Adkins, Douglas ;
Clark, Joseph ;
Sarlis, Nicholas ;
Lorch, Jochen ;
Beitler, Jonathan J. ;
Limaye, Sewanti ;
Riley, Sarah ;
Posner, Marshall .
LANCET ONCOLOGY, 2013, 14 (03) :257-264
12